Delivery Order SPE2DB20D1102-SPE2DB25FC5WU

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.92 firm fixed-price delivery order contract is for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a specialty medical product. The contract has a period of performance through December 11, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,409.52, is for the procurement of HYPERTET 250 UNIT/ML SYRINGEML, a medical product. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,994.94 firm fixed-price delivery order is for 4566272036 HYPERTET 250 UNIT/ML SYRINGEML. The contract has a completion date of November 21, 2024 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HYPERTET 250 Unit/mL syringes. The contract has a ceiling value of $1,329.96 and was awarded on July 24, 2024, with an ultimate completion date of August 14, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,244.80 firm fixed price delivery order is for the supply of HYPERTET 250 UNIT/ML SYRINGEML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of HYPERTET 250 UNIT/ML SYRINGE medical products. The $10,972.17 contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is not operating under a set-aside designation for this award. This delivery order is likely part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,134 Firm Fixed Price Delivery Order is for the supply of 4565350217 – HYPERTET 250 UNIT/ML SYRINGEML, a medical product. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,512.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of HYPERTET 250 UNIT/ML SYRINGEML, a medical supply item, with a period of performance through January 3, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The federal contract award is for the delivery of HYPERTET 250 UNIT/ML SYRINGEML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price of $1,438.05 and a completion date of July 8, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of HYPERTET 250 UNIT/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $3,324.90 and is a firm fixed-price delivery order with an ultimate completion date of October 10, 2024. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB25FC5WU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERTET 250 UNIT/ML SYRINGEML medical devices. The $1,761.90 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract will be performed in Conshohocken, Pennsylvania, and has an ultimate completion date of January 24, 2025.

Generated 4/6/25, 12:44 AM